ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells

Xuefeng Liu, Virginie Ory, Sandra Chapman, +13

American Journal Of Pathology

c-mip Impairs Podocyte Proximal Signaling and Induces Heavy Proteinuria

Shaoyu Zhang, Maud Kamal, Karine Dahan, +14

Science Signaling

Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy

Hassan Izzedine, M. Mangier, Virginie Ory, +14

Kidney International

Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes

Vincent Audard, Shaoyu Zhang, Christiane Copie‐Bergman, +6

Blood

C-mip interacts physically with RelA and inhibits nuclear factor kappa B activity

Maud Kamal, Asta Valančiūtė, Karine Dahan, +4

Molecular Immunology

C-mip InteractsProtein FunctionSignal TransductionSignaling PathwayCell Regulation +6

Conditionally Reprogrammed Normal and Transformed Mouse Mammary Epithelial Cells Display a Progenitor-Cell–Like Phenotype

Francisco Sáenz, Virginie Ory, Maram Alotaibi, +8

PLoS ONE

c-mip Down-Regulates NF-κB Activity and Promotes Apoptosis in Podocytes

Virginie Ory, Qingfeng Fan, Nabila Hamdaoui, +8

American Journal Of Pathology

InflammationCytokineSignal TransductionSignaling PathwayCell Signaling +7

Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression

Max H. Kushner, Virginie Ory, Garrett T. Graham, +7

EMBO Reports

Aib1/yap TargetsAnco1 RepressionBreast OncologyMedicineCancer Cell Biology +8

Pleiotrophin (PTN) Expression and Function and in the Mouse Mammary Gland and Mammary Epithelial Cells

Sonia Rosenfield, Emma T. Bowden, Shani Cohen-Missner, +5

PLoS ONE

ImmunologyCell ProliferationCellular PhysiologyMammary Gland DevelopmentMammary Glands +17

The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ

Virginie Ory, William B. Kietzman, Jacob Boeckelman, +4

Breast Cancer Research and Treatment

Tumor BiologyInvasive ProgressionMedicinePparγ Agonist EfatutazoneCancer Cell Biology +8